Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CEO and director Edward A. Pesicka plans retirement by year-end 2026 or earlier successor appointment.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO and director Edward A. Pesicka plans retirement by year-end 2026 or earlier successor appointment
- Board succession search underway, creating leadership-transition uncertainty
- Departure unrelated to disagreements over operations, policies, or practices
Item 7.01 · Regulation FD Disclosure
- Section 7.01 disclosure contains only standard Regulation FD filing-liability language
- No substantive company update or investor-actionable information disclosed
Item EX-99.1 · Exhibit EX-99.1
- CEO Edward A. Pesicka plans retirement by year-end 2026 after more than seven years
- Board succession search underway, with previously identified candidates supporting transition planning
- Pesicka will also leave the Board and may remain as an advisor beyond retirement
- Leadership change follows divestiture of Owens & Minor, balance-sheet optimization, and management restructuring
- CEO transition creates execution and strategic-continuity risk despite planned succession process
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.